A novel organotypic model mimics the tumor microenvironment.
Carcinoma cell invasion is traditionally studied in three-dimensional organotypic models composed of type I collagen and fibroblasts. However, carcinoma cell behavior is affected by the various cell types and the extracellular matrix (ECM) in the tumor microenvironment. In this study, a novel organotypic model based on human uterine leiomyoma tissue was established and characterized to create a more authentic environment for carcinoma cells. Human tongue squamous cell carcinoma cells (HSC-3) were cultured on top of either collagen or myoma. Organotypic sections were examined by immunohistochemistry and in situ hybridization. The maximal invasion depth of HSC-3 cells was markedly increased in myomas compared with collagen. In myomas, various cell types and ECM components were present, and the HSC-3 cells only expressed ECM molecules in the myoma model. Organotypic media were analyzed by radioimmunoassay, zymography, or Western blotting. During carcinoma cell invasion, matrix metalloprotease-9 production and collagen degradation were enhanced particularly in the myoma model. To evaluate the general applicability of the myoma model, several oral carcinoma, breast carcinoma, and melanoma cell lines were cultured on myomas and found to invade in highly distinct patterns. We conclude that myoma tissue mimics the native tumor microenvironment better than previous organotypic models and possibly enhances epithelial-to-mesenchymal transition. Thus, the myoma model provides a promising tool for analyzing the behavior of carcinoma cells.
Nurmenniemi
Sini
S
Department of Diagnostics and Oral Medicine, Institute of Dentistry, University of Oulu, Oulu, Finland. tuula.salo@oulu.fi
Sinikumpu
Teemu
T
Alahuhta
Ilkka
I
Salo
Sirpa
S
Sutinen
Meeri
M
Santala
Markku
M
Risteli
Juha
J
Nyberg
Pia
P
Salo
Tuula
T
D001943:Breast Neoplasms / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000378:metabolism / Q000473:pathology*; D002450:Cell Communication; D018920:Coculture Techniques; D003094:Collagen; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000378:metabolism / Q000473:pathology*; D020780:Matrix Metalloproteinase 9 / Q000096:biosynthesis; D008545:Melanoma / Q000473:pathology; D008954:Models, Biological; D009062:Mouth Neoplasms / Q000473:pathology; D009361:Neoplasm Invasiveness; D009924:Organ Culture Techniques; D014062:Tongue Neoplasms / Q000378:metabolism / Q000473:pathology*; D014594:Uterine Neoplasms / Q000378:metabolism / Q000473:pathology*
D003094:Collagen; D020780:Matrix Metalloproteinase 9
J Biol Chem. 1985 Jun 25;260(12):7681-7
2581969
Nat Cell Biol. 2007 Dec;9(12):1392-400
18037882
Nat Rev Cancer. 2006 May;6(5):392-401
16572188
Int J Cancer. 1992 Dec 2;52(6):896-902
1459732
Br J Cancer. 2008 Feb 26;98(4):766-75
18253113
Cell Cycle. 2006 Aug;5(15):1597-601
16880743
Clin Chem. 1993 Apr;39(4):635-40
8472358
Mol Carcinog. 1997 Aug;19(4):258-66
9290703
Am J Pathol. 2006 Jun;168(6):1889-97
16723704
J Cell Biol. 1992 Nov;119(3):679-93
1383240
Nat Rev Mol Cell Biol. 2008 Aug;9(8):628-38
18628784
J Cancer Res Clin Oncol. 1995;121(9-10):542-8
7559734
J Pathol. 2005 Mar;205(4):468-75
15685705
Nat Rev Cancer. 2004 Nov;4(11):839-49
15516957
J Oral Pathol Med. 2004 Feb;33(2):71-8
14720192
Arch Dermatol Res. 2002 Jul;294(4):178-84
12111348
Int J Cancer. 2002 May 10;99(2):157-66
11979428
Oral Oncol. 2000 Jul;36(4):365-72
10899676
J Clin Endocrinol Metab. 1994 Sep;79(3):900-6
8077380
Br J Cancer. 1999 May;80(5-6):733-43
10360651
Nucleic Acids Res. 1988 Jan 11;16(1):349
3340531
Arterioscler Thromb Vasc Biol. 1999 Jun;19(6):1506-11
10364082
Arch Dermatol Res. 1987;279(3):154-60
3592743
Methods Enzymol. 1987;145:391-411
3600399
Eur J Biochem. 1983 Apr 5;131(3):481-7
6682377
Am J Respir Cell Mol Biol. 2008 Jan;38(1):95-104
17673689
Matrix. 1989 Mar;9(2):82-91
2725424
N Engl J Med. 1971 Nov 18;285(21):1182-6
4938153
Nature. 2002 Dec 19-26;420(6917):860-7
12490959
Br J Cancer. 2008 Nov 4;99(9):1375-9
18797460
J Biol Chem. 2003 Jun 20;278(25):22404-11
12690120
J Dent Res. 1996 Mar;75(3):919-26
8675803
Cancer Res. 2005 Oct 1;65(19):8944-50
16204067
J Invest Dermatol. 1983 Jul;81(1 Suppl):168s-75s
6190961
J Biol Chem. 1999 May 7;274(19):13066-76
10224058
Front Biosci. 2008 May 01;13:6537-53
18508679